8 Results for "

methuosis

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "methuosis" in MCE Product Catalog:

Cat. No.: HY-112440
CAS No.: 2240205-30-3
Purity:  99.40%
Synonyms: methuosis inducer 1
HZX-02-059 is an allosteric inhibitor of PIKFYVE, and a methuosis inducer. HZX-02-059 disrupts the PIKfyve/TFEB axis, suppresses tubulin polymerization, reduces phosphorylated mTOR levels, downregulates p53, PI3K/AKT, c-Myc, and NF-κB pathways. HZX-02-059 induces G2/M cell cycle arrest, apoptosis, and inhibits cancer cell proliferation. HZX-02-059 can be used for the research of lymphoma, double-hit lymphoma, and B-cell acute lymphoblastic leukemia .
loading...
    loading...
Cat. No.: HY-N1180
CAS No.: 105351-70-0
Tanshinlactone is a compound found in Salvia miltiorrhiza with anti-coronavirus (CoV) and anti-tumor activities. Tanshinlactone induces methuocytic cell death (methuosis) by activating the NRF2 pathway, and selectively kills ER +, HER2 +/EGFR + breast cancer cells. Tanshinlactone is applicable to research related to breast cancer and coronavirus infections .
loading...
    loading...
Cat. No.: HY-148114
CAS No.: 1485521-76-3
Target:  

Autophagy

Research Areas:  

Neurological Disease Cancer

MOPIPP is a novel indolebased chalcone, and vacuolin-1, is a non-lethal vacuoleinducing 2-propyl analog of MOMIPP (HY-119624). MOPIPP induces cellular vacuolization and increases autophagosomes numbers. MOPIPP can be used for the study of glioblastoma cells .
loading...
    loading...
Cat. No.: HY-177120
CAS No.: 133156-42-0
Target:  

Autophagy

Research Areas:  

Cancer

DMBP is a VPS41 inhibitor. DMBP induces methuosis and inhibits autophagy in cancer cells. DMBP inhibits the fusion of late endosomes and autophagosomes with lysosomes. DMBP effectively inhibits metastasis in a mouse metastatic melanoma model. DMBP can be used for the study of melanoma .
loading...
    loading...
Cat. No.: HY-144624
CAS No.: 3033401-47-4
Target:  

PROTACs TAM Receptor Ras

Research Areas:  

Cancer

PROTAC Axl Degrader 1 is an orally active PROTAC degrader targeting the AXL receptor tyrosine kinase, with an IC50 of 0.92 μM against human targets. PROTAC Axl Degrader 1 induces cytoplasmic vacuolization, methuosis (macropinocytosis-induced cell death), excessive macropinosome production, and Rac1 activation. PROTAC Axl Degrader 1 inhibits the proliferation and migration of cancer cells. PROTAC Axl Degrader 1 can be used in breast cancer-related research .
loading...
    loading...
Cat. No.: HY-50733
CAS No.: 1009821-06-0
Research Areas:  

Cancer

CX-5011 free base is a potent CK2 inhibitor. CX-5011 free base also is a Rac-1 activator. CX-5011 free base induces methuosis and promotes macropinocytosis. CX-5011 free base induces apoptosis. CX-5011 free base decreases the expression of rpS6 phosphorylation .
loading...
    loading...
Cat. No.: HY-149847
CAS No.: 2928616-74-2
Target:  

Ras

Research Areas:  

Cancer

JH530 is an effective methuosis inducer that inhibits the triple-negative breast cancer (TNBC) cells proliferation by causing intracellular complete vacuolization. JH530 has anti-tumor activity and can be used for cancer research .
loading...
    loading...
Cat. No.: HY-184184
CAS No.: 3033401-32-7
Axl ligand-1 is a highly selective ligand for AXL kinase, exhibiting higher selectivity for AXL over 72 human kinases. Axl ligand-1 serves as a Ligand for Target Protein for PROTAC, which is applied to develop PROTAC degraders with anti-tumor activity, such as PROTAC Axl Degrader 1 (HY-144624). Axl ligand-1 is applicable to breast cancer-related research .
loading...
    loading...